Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125927792 | 12592779 | 2 | F | 20160713 | 20160726 | 20160726 | EXP | US-CIPLA LTD.-2016US09828 | CIPLA | 0.00 | Y | 0.00000 | 20160726 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125927792 | 12592779 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 2.5 MG, UNK | Y | 77955 | 2.5 | MG | |||||||
125927792 | 12592779 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK | Y | 77955 | |||||||||
125927792 | 12592779 | 3 | SS | VALSARTAN. | VALSARTAN | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125927792 | 12592779 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125927792 | 12592779 | Arthralgia | |
125927792 | 12592779 | Joint swelling | |
125927792 | 12592779 | Muscle spasms | |
125927792 | 12592779 | Musculoskeletal stiffness | |
125927792 | 12592779 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |